176 related articles for article (PubMed ID: 33882561)
1. Artificial intelligence in bladder cancer prognosis: a pathway for personalized medicine.
Pinar U; Pradere B; Roupret M
Curr Opin Urol; 2021 Jul; 31(4):404-408. PubMed ID: 33882561
[TBL] [Abstract][Full Text] [Related]
2. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
Martini A; Lonati C; Montorsi F; Briganti A; Colombo R; Necchi A; Simeone C; Zamboni S; Afferi L; Mattei A; Carando R; Ploussard G; Soria F; Marra G; Rouprêt M; Xylinas E; Pradere B; Abufaraj M; D'Andrea D; Shariat SF; Moschini M
Clin Genitourin Cancer; 2022 Jun; 20(3):e190-e198. PubMed ID: 35105509
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction.
Borhani S; Borhani R; Kajdacsy-Balla A
Crit Rev Oncol Hematol; 2022 Mar; 171():103601. PubMed ID: 35065220
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
Chen MK; Chen ZJ; Xiao KH; Qin ZK; Ye YL; Wen WJ; Bian J; Xue KY; Zhou QZ; Guo WB; Zhou JH; Xia M; Li X; Liu CD
Jpn J Clin Oncol; 2020 Apr; 50(4):456-464. PubMed ID: 31894237
[TBL] [Abstract][Full Text] [Related]
5. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer.
Jobczyk M; Stawiski K; Kaszkowiak M; Rajwa P; Różański W; Soria F; Shariat SF; Fendler W
Eur Urol Oncol; 2022 Feb; 5(1):109-112. PubMed ID: 34092528
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
[TBL] [Abstract][Full Text] [Related]
8. Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Kozikowski M; Suarez-Ibarrola R; Osiecki R; Bilski K; Gratzke C; Shariat SF; Miernik A; Dobruch J
Eur Urol Focus; 2022 May; 8(3):728-738. PubMed ID: 34099417
[TBL] [Abstract][Full Text] [Related]
9. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
Wang H; Xu X; Zhang X; Liu Y; Ouyang L; Du P; Li S; Tian Q; Ling J; Guo Y; Lu H
Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
[TBL] [Abstract][Full Text] [Related]
10. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application.
Meng Y; Yang Y; Hu M; Zhang Z; Zhou X
Semin Cancer Biol; 2023 Oct; 95():75-87. PubMed ID: 37499847
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review.
Bazarkin A; Morozov A; Androsov A; Fajkovic H; Rivas JG; Singla N; Koroleva S; Teoh JY; Zvyagin AV; Shariat SF; Somani B; Enikeev D
Curr Urol Rep; 2024 Jan; 25(1):19-35. PubMed ID: 38099997
[TBL] [Abstract][Full Text] [Related]
13. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
[TBL] [Abstract][Full Text] [Related]
14. Multi-task deep learning based on T2-Weighted Images for predicting Muscular-Invasive Bladder Cancer.
Zou Y; Cai L; Chen C; Shao Q; Fu X; Yu J; Wang L; Chen Z; Yang X; Yuan B; Liu P; Lu Q
Comput Biol Med; 2022 Dec; 151(Pt A):106219. PubMed ID: 36343408
[TBL] [Abstract][Full Text] [Related]
15. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J
Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894
[TBL] [Abstract][Full Text] [Related]
16. Nonmuscle-invasive bladder cancer, old problems, new insights.
Compérat E; Wasinger G; Oszwald A; Pradere B; Shariat S
Curr Opin Urol; 2022 Jul; 32(4):352-357. PubMed ID: 35749782
[TBL] [Abstract][Full Text] [Related]
17. Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
Bartsch G; Mitra AP; Mitra SA; Almal AA; Steven KE; Skinner DG; Fry DW; Lenehan PF; Worzel WP; Cote RJ
J Urol; 2016 Feb; 195(2):493-8. PubMed ID: 26459038
[TBL] [Abstract][Full Text] [Related]
18. Smoking and bladder cancer: review of the recent literature.
Mori K; Mostafaei H; Abufaraj M; Yang L; Egawa S; Shariat SF
Curr Opin Urol; 2020 Sep; 30(5):720-725. PubMed ID: 32701723
[TBL] [Abstract][Full Text] [Related]
19. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.
van den Bosch S; Alfred Witjes J
Eur Urol; 2011 Sep; 60(3):493-500. PubMed ID: 21664041
[TBL] [Abstract][Full Text] [Related]
20. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
